a company, which engages in developing bacteriophage-based therapies for the treatment and prevention of diseases stemming from dysbiosis of the microbiome
Industry InformationTechnologyServices
This indicator may be signaling that PHGE's price has momentum to move higher, since its current price exceeds the price logged 14 days ago. Traders may consider buying the stock or exploring call options. A.I.dvisor backtested 90 similar cases where PHGE's Momentum Indicator exceeded 0, and of them led to a successful outcome. Odds of Success: